Viewing nowHwanin Memantine Tablet 5 mg (Memantine Hydrochloride)
Memantine Hydrochloride 5mg
Tablet · Prescription medication
Hwanin Pharmaceutical Co., Ltd.

MFDS item code 202500214 · Approved 2025.02.03 · Insurance code 657204270
Treatment of moderate to severe Alzheimer's disease
This medication is used for patients with moderate to severe Alzheimer's disease. Alzheimer's disease is a neurodegenerative disorder characterized by a gradual decline in memory and cognitive function, and this drug helps slow the progression of symptoms and improve function. It plays a crucial role in maintaining the patient's ability to perform daily activities. It is effective in treating moderate to severe stages of Alzheimer's disease and contributes to symptom relief.
This medication is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. It may be taken with or without food. 1. Adults Dose titration: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Days 1–7): Administer 5mg once daily for 7 days. Week 2 (Days 8–14): Administer 10mg once daily for 7 days. Week 3 (Days 15–21): Administer 15mg once daily for 7 days. From Week 4 onward, administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults Based on clinical data, the recommended dose for older patients aged 65 years and over is 20mg once daily. 3. Patients with renal impairment No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), the daily dose should be reduced to 10mg. If the medication is well tolerated after at least 7 days of treatment, the dose may be increased to 20mg once daily according to the standard dose-titration schedule. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medication.
This medication should not be used by patients with allergies to its components, severely impaired liver function, or severely impaired kidney function. Caution is advised for patients with epilepsy or a history of seizures, as well as those prone to seizures. Moreover, using NMDA antagonists such as amantadine, ketamine, or dextromethorphan concurrently can increase central nervous system side effects, so they should not be co-administered. Patients with factors that increase urinary acidity (pH), such as significant dietary changes, excessive consumption of alkaline beverages, or specific kidney diseases or urinary tract infections, should be monitored closely. There is insufficient safety data for patients with recent myocardial infarction, congestive heart failure, or uncontrolled hypertension, so caution is advised in these cases. During the use of this medication, side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur, most of which are mild to moderate symptoms. Rarely, neurological abnormal reactions such as confusion, hallucinations, and seizures may also occur, so if any unusual symptoms appear, immediate consultation with a physician is recommended. This medication can interact with other drugs, particularly NMDA antagonists, antipsychotic medications, muscle relaxants, anticoagulants, and gastrointestinal medications. It is essential to consult a healthcare professional before co-administration. Women who are pregnant or may become pregnant should carefully consider the risks to the fetus when taking this medication, and breastfeeding is not recommended while on this medication. It is best not to use this medication in children and adolescents under 18 years of age as its safety and efficacy have not been established for this age group. In case of overdose, severe symptoms may be observed in the central nervous system and gastrointestinal tract, so immediate medical attention is necessary. Lastly, this medication may impair reaction time and attention, so special caution is required during driving or operating machinery. Finally, this medication should be stored out of the reach of children, and transferring it to another container should be avoided to ensure safety and maintain the quality of the medication.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent air exposure, ideally at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the medication's effectiveness for a longer period.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMemantine Hydrochloride 5mg
Tablet · Prescription medication
Hwanin Pharmaceutical Co., Ltd.
Memantine Hydrochloride 1g
Solution · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Myongin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.